Shanghai United Imaging Healthcare Co., Ltd. (SHSE:688271) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Simply Wall StJan 8 22:03 ET

CMB International: With continued policy efforts, Bullish on the rebound of China Meheco Group's valuation.

Benefiting from overseas interest rate cuts and improvements in the domestic macro environment, the pharmaceutical sector, as a high-elasticity Industry, is expected to outperform the market in 2025.

Zhitong FinanceJan 8 03:34 ET

Guolian: It is the right time for domestic medical instruments to go global. Focus on leading companies with first-mover advantages in going abroad.

Domestic medical instruments have advantages in production, manufacturing, and upgrades, laying a foundation for products to go global, and the Global medical instruments market has vast potential.

Zhitong FinanceJan 2 02:02 ET

United Imaging Medical (688271.SH): plans to invest 28.4872 million yuan in Asia Vets.

On December 20, Glonghui reported that United Imaging Medical (688271.SH) announced that the company is using 28.4872 million yuan of its own funds to invest in Asia Vets. The Board of Directors has authorized the management to handle matters including but not limited to contract signing and fund disbursement. In this Trade, United Imaging Group intends to acquire a 2.0000% stake in Asia Vets after the capital increase with its own funds, while Shanghai Lianhe plans to acquire a 1.7901% stake in Asia Vets after the capital increase with its own funds. Given that United Imaging Group is the controlling Shareholder of the company, and Shanghai Lianhe directly holds more than 5% of the company's shares, Asia Vets is under the control of the company's controlling Shareholder, United Imaging Group.

Gelonghui FinanceDec 20, 2024 07:31 ET

Is Shanghai United Imaging Healthcare Co., Ltd. (SHSE:688271) Expensive For A Reason? A Look At Its Intrinsic Value

Simply Wall StDec 18, 2024 21:26 ET

United Imaging Medical (688271.SH): has mastered the core technology of the integrated Computed Tomography guided linear accelerator system.

On December 16, Gelonghui reported that United Imaging (688271.SH) stated on the investor interaction platform that in the field of radiotherapy, the company has mastered the core technology of the integrated Computed Tomography guided linear accelerator system and has achieved independent research and development and production of major core components.

Gelonghui FinanceDec 16, 2024 05:28 ET